TIP
VRTX icon

Torray Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Torray Investment Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.87M Sell
15,386
-80
-0.5% -$37.3K 1.01% 30
2025
Q4 		$7.01M Sell
15,466
-789
-5% -$340K 1% 31
2025
Q3 		$6.37M Sell
16,255
-624
-4% -$261K 0.86% 40
2025
Q2 		$7.51M Buy
16,879
+1,158
+7% +$534K 1.09% 33
2025
Q1 		$7.62M Sell
15,721
-287
-2% -$134K 1.14% 34
2024
Q4 		$6.45M Buy
16,008
+257
+2% +$119K 0.92% 40
2024
Q3 		$7.33M Buy
15,751
+1,813
+13% +$871K 1.03% 33
2024
Q2 		$6.53M Buy
13,938
+39
+0.3% +$16.9K 0.98% 38
2024
Q1 		$5.81M Sell
13,899
-169
-1% -$71.4K 0.87% 40
2023
Q4 		$5.72M Buy
+14,068
New +$5.2M 0.93% 40
2014
Q2 		– Sell
-76,397
Closed -$5.4M – 94
2014
Q1 		$5.4M Buy
76,397
+22,117
+41% +$1.75M 0.92% 54
2013
Q4 		$4.03M Buy
54,280
+8,310
+18% +$579K 0.84% 47
2013
Q3 		$3.48M Buy
45,970
+598
+1% +$47.6K 0.75% 49
2013
Q2 		$3.63M Buy
+45,372
New +$3.34M 0.79% 46

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Torray Investment Partners's VRTX Position: Q1 2026 in Review

Torray Investment Partners reduced its Vertex Pharmaceuticals (VRTX) stake by 0.52% in Q1 2026, selling an estimated $37.3K and leaving 15,386 shares worth $6.87M. The position accounts for 1.01% of the portfolio, ranked #30.

Torray Investment Partners first reported a position in VRTX in Q2 2013 and has held it in 14 quarters since. The position peaked at $7.62M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Torray Investment Partners held 15,386 shares of Vertex Pharmaceuticals worth $6.87M as of Q1 2026.
  • Torray Investment Partners sold 80 Vertex Pharmaceuticals shares in Q1 2026, an estimated $37.3K.
  • Vertex Pharmaceuticals made up 1.01% of Torray Investment Partners's portfolio in Q1 2026, its #30 holding.
  • Torray Investment Partners first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
  • Torray Investment Partners's Vertex Pharmaceuticals position peaked at $7.62M in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Torray Investment Partners's 13F filing for Q1 2026, filed 1 May 2026.